SHANGHAI – Sanofi SA, of Paris, has chosen a Shanghai address for its Asia Pacific R&D Hub. Its fifth hub, it will coordinate a complex research network across 12 Asian countries, and 50 collaborations pursuing the pharma's model of borderless, "open innovation."